Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[The cost-effectiveness of interferon beta treatment in patients with a clinically isolated syndrome in Colombia].
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Allopregnanolone: State of the art.
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Olfactory dysfunction in patients with neuromyelitis optica.
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Development of the Oxford Participation and Activities Questionnaire: constructing an item pool.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Functional neuroimaging may quantify spinal cord demyelinating disease.
Neuronal Hemoglobin Expression and Its Relevance to Multiple Sclerosis Neuropathology.
The relationship of age with the clinical phenotype in multiple sclerosis.
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
Epigenetic Drugs for Multiple Sclerosis.
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.
Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence.
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Acute autonomic, sensory and motor neuropathy associated with meningoencephalitis.
Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.
Carbon Monoxide and Central Nervous System: Challenges and Achievements.
The potential of epigenetic therapies in neurodegenerative diseases.
Microglia and neuroprotection.
Therapeutic management of severe relapses in multiple sclerosis.
PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling.

Pages